STAT
MARCH 20, 2025
NEW YORK — A former top federal health official is publicly warning Robert F. Kennedy Jr. that wavering on vaccines and slashing federal programs during a deadly measles outbreak could unleash the next public health disaster. “The federal government might pause, but the measles virus doesn’t pause. Bacteria and viruses don’t pause.
Drug Topics
MARCH 20, 2025
Cencora representatives with expertise into pharmacy desert insights joined Drug Topics to discuss issues in pharmacy access and what is being done to address them.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 20, 2025
TriCare, the federal health insurer for the military, has temporarily stopped paying the medical claims of pain management device maker Zynex Medical. In a recent filing with the Securities and Exchange Commission, Zynex revealed that the government payer — which represents up to a quarter of Zynex’s annual revenue — was suspending payments as it reviewed prior claims.
Drug Topics
MARCH 20, 2025
Don Roosan, PharmD, PhD, joined Drug Topics to explore the future of ChatGPT in pharmacy practice and how AI is being used to manage patients medication regimens.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
MARCH 20, 2025
Wholesale egg prices have dropped by more than 40% since late February, a decline that should soon translate into broader savings for consumers at grocery stores. This welcome respite has largely resulted from the lull in significant bird flu outbreaks in recent weeks, perhaps due to seasonal patterns in the virus’s transmission. North American flyways typically remain quiet in February as migratory birds have yet to start their journeys from their winter habitats.
Drug Topics
MARCH 20, 2025
Pharmacists play a critical role in public education, and the potential for expanding clinical services is evident.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
MARCH 20, 2025
Jade Ranger, PharmD, co-owner and pharmacist at the Prescription Shoppe, discussed administering vaccines during the COVID-19 pandemic.
STAT
MARCH 20, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! There’s sure to be a lot of news coming out of the Breakthrough Summit East today, which is taking place just a few blocks away from my favorite Shake Shack in Manhattan. In-person tickets are sold out, but you can still snag a virtual ticket here.
Drug Topics
MARCH 20, 2025
Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, clinical associate professor at University at Buffalo, discusses how pharmacists and patients view injectable contraception.
STAT
MARCH 20, 2025
Top of the morning to you, and a fine one it is, despite the dreary gray skies hovering over the Pharmalot campus. We are doing our best to maintain sunny spirits, though, because once again, we recall some helpful wisdom from the Morning Mayor, who taught us that “every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and inviting you to join us.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
MARCH 20, 2025
Discontinuing SSRIs or SNRIs during pregnancy did not lead to an increase in hospitalizations, outpatient visits, suicidal behavior, or sick leave use.
Pharmacy Times
MARCH 20, 2025
Panelists discuss how antibody-drug conjugates (ADCs) often show more diverse outcomes in real-world settings compared with clinical trials, with varying efficacy and adverse effect profiles. Key practical considerations for pharmacists include appropriate dosing based on patient factors, managing drug interactions, implementing premedication protocols to minimize adverse reactions, and providing comprehensive supportive care.
Drug Topics
MARCH 20, 2025
Control-IQ+ was associated with a greater reduction in glycated hemoglobin compared to a continuous glucose monitor alone.
STAT
MARCH 20, 2025
NEW YORK — In his first public comments, Pfizer’s new innovation chief — once a Wall Street analyst skeptical of the company — said he was confident in the company’s obesity plans and shed light on why he joined the pharmaceutical giant. Andrew Baum was managing director of equity research at Citigroup until last May, when Pfizer announced that he would take on the role of chief strategy and innovation officer.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
MARCH 20, 2025
Panelists note how medical professionals discuss menopause therapy, addressing symptoms, treatment options, safety concerns, adverse events, and personalized management strategies through patient-centered care. Professionals prioritize transparent communication, comprehensive risk assessment, and collaborative decision-making to ensure patient comfort and optimal management of menopausal transition.
STAT
MARCH 20, 2025
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. A panel of experts at a leading speciality society announced in a new clinical guideline that they have decided not to decide whether to recommend AI-assisted colonoscopies.
Pharma Marketing Network
MARCH 20, 2025
Introduction The healthcare industry is undergoing a significant transformation, and ad budgeting is at the center of this shift. With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025.
STAT
MARCH 20, 2025
The GLP-1 class of drugs used to treat diabetes and obesity may have the potential to benefit huge swaths of the public, but ongoing employer concerns over cost and a lack of patient adherence remain stubborn obstacles to wider adoption, a pair of health executives explained Thursday. The medicines have proven wildly popular and, in turn, have generated huge sales, long stretches of shortages, and unchecked excitement among investors.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Checkup by Singlecare
MARCH 20, 2025
Eliquis (apixaban) and aspirin are both oral drugs that decrease blood clotting, but that is where their similarities end. They thin the blood by very different mechanisms and are used for different medical conditions. How effective one is versus the other depends on the condition being treated. And their side effects and costs are quite different. Well compare and contrast Eliquis and aspirin so you better understand why your healthcare provider may recommend one over the other.
PharmaVoice
MARCH 20, 2025
The death of a 16-year-old boy evokes a lengthy battle to realize the benefit of cutting-edge gene therapy while also enduring tragic risk.
The Checkup by Singlecare
MARCH 20, 2025
There are several reasons one may consider taking Zyrtec and Pepcid together. They both block histamine receptors, but their mechanisms are different enough to have additive benefits. Zyrtec (cetirizine) is an antihistamine used for allergies , while Pepcid (famotidine) blocks gastric histamine-2 (H2) receptors and thereby decreases stomach acid production in the treatment of gastroesophageal reflux disease (GERD) and stomach ulcers.
Pharma Marketing Network
MARCH 20, 2025
Introduction The pharmaceutical industry faces unique challenges in digital marketing, especially when it comes to reaching healthcare professionals (HCPs) and patients effectively. Ad retargeting has become a powerful tool for pharma marketers, enabling brands to re-engage potential customers who have shown interest but have not yet converted. But how does ad retargeting work in pharma marketing, and what strategies yield the best results?
The Checkup by Singlecare
MARCH 20, 2025
GLP-1 receptor agonists have greatly changed how we treat diabetes and obesity in recent years. Popular medications like Ozempic , Wegovy , and Zepbound have become popular not only for their ability to manage blood sugar levels but also for their impressive weight loss benefits. Beyond diabetes and weight loss, the use of GLP-1 medications is expanding into treatment for kidney disease, peripheral neuropathy, and potentially even dementia.
Fierce Healthcare
MARCH 20, 2025
Optum Rx is shifting its payment models to better meet the needs of pharmacies and consumers, the pharmacy benefit manager announced Thursday. | Optum Rx is shifting its payment models to better meet the needs of pharmacies and consumers, the pharmacy benefit manager announced Thursday.
Pharmaceutical Technology
MARCH 20, 2025
OBT has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment.
pharmaphorum
MARCH 20, 2025
A study has suggested early targeting of amyloid in the brains of people with inherited Alzheimer's can delay symptoms, but not all are convinced.
Pharmacy Times
MARCH 20, 2025
Health care professionals in the study found it challenging to manage the complexities of disordered eating in patients with type 1 diabetes alongside their other responsibilities.
Fierce Healthcare
MARCH 20, 2025
Health tech company Inspiren developed intelligent AI-powered solutions for senior living that integrates care planning, resident safety, staff efficiency and emergency call functionalities into one system.
Pharmacy Times
MARCH 20, 2025
Community pharmacists are uniquely positioned to assist with diabetes management using CGM devices.
pharmaphorum
MARCH 20, 2025
Brain-computer interface specialist Synchron has previewed an AI model that it believes will form the basis of a new generation of devices.
Pharmaceutical Technology
MARCH 20, 2025
Pfizer has divested its residual shareholding in Haleon, representing 7.3% of the company's share capital, for a total of $3.3bn.
pharmaphorum
MARCH 20, 2025
UK pharma leaders have renewed calls for a rethink by the government on levies imposed on medicine sales, saying investment is already being hit.
Pharmacy Times
MARCH 20, 2025
The launch of ustekinumab-stba following its FDA approval expands patient access to this therapy with a variety of indications.
Expert insights. Personalized for you.
140 
Let's personalize your content